GLABF (Gemina Laboratories) Other Operating Expense: $-0.00 Mil (TTM As of Oct. 2025)


What is Gemina Laboratories Other Operating Expense?

Gemina Laboratories GLABF -27.59% Other Operating Expense is $-0.00 Mil as of Oct. 2025. The stock has 2 warning signs investors should review.

Gemina Laboratories's Other Operating Expense for the three months ended in Oct. 2025 was $-0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Oct. 2025 was $-0.00 Mil.

Gemina Laboratories's quarterly Other Operating Expense stayed the same from Apr. 2025 ($0.00 Mil) to Jul. 2025 ($0.00 Mil) but then declined from Jul. 2025 ($0.00 Mil) to Oct. 2025 ($-0.00 Mil).

Gemina Laboratories's annual Other Operating Expense declined from Jan. 2023 ($0.02 Mil) to Jan. 2024 ($-0.00 Mil) but then stayed the same from Jan. 2024 ($-0.00 Mil) to Jan. 2025 ($-0.00 Mil).

Gemina Laboratories Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Gemina Laboratories's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories Other Operating Expense Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24 Jan25
Other Operating Expense
0.00 0.04 0.02 -0.00 -0.00

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.00

Gemina Laboratories Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $-0.00 Mil mean?
Gemina Laboratories (GLABF) has a Other Operating Expense of $-0.00 Mil as of Oct. 2025. Other operating expenses that a company records on its income statement. View historical data on Gemina Laboratories and its competitors.
Is Gemina Laboratories' Other Operating Expense too high?
Gemina Laboratories' current Other Operating Expense is $-0.00 Mil.
How does Gemina Laboratories' Other Operating Expense compare to VRTX and REGN?
Gemina Laboratories' Other Operating Expense of $-0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Gemina Laboratories and its competitors. Gemina Laboratories's current Other Operating Expense is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gemina Laboratories stock overvalued right now?
Gemina Laboratories (GLABF) has a current Other Operating Expense of $-0.00 Mil. The current Other Operating Expense is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Gemina Laboratories (GLABF), the current Other Operating Expense is $-0.00 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gemina Laboratories Business Description

Address 3600 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.